Myant Acquires mmHg Inc. To Enhance Precision Medicine for Cardiovascular Care | PR Newswire [Video]

, /PRNewswire/ — Myant Corp., a leader in chronic disease prevention through precision medicine, announced the acquisition of mmHg Inc., a digital health company specializing in remote blood pressure monitoring, cardiovascular risk reduction, and chronic disease management. This acquisition expands Myant’s geographic footprint and market reach to the USA, where mmHg has a significant existing customer base, including a partnership with one of the largest manufacturers of highly accurate, reliable medical devices and health products, A&D Medical.

This acquisition is part of a broader strategy of “prevention through precision” to drive forward a new era of personalized, AI-enabled remote healthcare.

mmHg’s platform focuses on delivering efficient, guideline-concordant care for managing cardiovascular health, particularly in remote settings. Healthcare providers gain the capability to remotely track and analyze blood pressure and a spectrum of vital cardiovascular indicators through its innovative software. By aligning patient data with clinical best practices, mmHg enhances decision-making …